Pilot Study of Head Cooling in Preterm Infants With Hypoxic Ischemic Encephalopathy
NCT00620711 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2019-01-29
Summary
The hypothesis is that premature infants' can have enough cooling applied to cool their brain to decrease CNS injury without cooling their body.
Conditions
- Hypoxic Ischemic Encephalopathy
Interventions
- DEVICE
-
Olympic Cool Cap
Olympic Cool Cap will be applied to infants 32-35 weeks gestation who meet criteria for HIE.
Sponsors & Collaborators
-
Vanderbilt University
lead OTHER
Principal Investigators
-
Willaim F Walsh, MD · Vanderbilt University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Minutes
- Max Age
- 6 Hours
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Moderate Hypothermia in Neonatal Hypoxic Ischemic Encephalopathy
NCT02826941 ·Status: COMPLETED ·Phase: PHASE2
-
Cooling in Mild Encephalopathy
NCT05889507 ·Status: RECRUITING ·Phase: PHASE3
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
NCT05853601 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The TOBY Children Study
NCT01092637 ·Status: COMPLETED
-
Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy
NCT00817401 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy
NCT03835039 ·Status: TERMINATED
-
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
NCT02793999 ·Status: RECRUITING
-
Hypothermia Therapy in Pediatric Cardiac Intensive Care Unit for Suspected for Brain Injury
NCT02395276 ·Status: UNKNOWN ·Phase: NA
-
Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy
NCT07018739 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
NCT01471015 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MRI of Neonate With HIE Before and During the Moderate Hypothermia
NCT03079492 ·Status: UNKNOWN
-
Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy
NCT01904786 ·Status: WITHDRAWN ·Phase: PHASE1
-
Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
NCT01732146 ·Status: COMPLETED ·Phase: PHASE3
-
Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
NCT02800018 ·Status: COMPLETED
-
Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
NCT02881970 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants
NCT03640494 ·Status: COMPLETED
-
Metformin Treatment in Infants After Perinatal Brain Injury
NCT05590676 ·Status: TERMINATED ·Phase: PHASE1
-
Amnioinfusion for Intrauterine Neuroprotection
NCT05513690 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Imaging and Spectroscopy Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy
NCT01481207 ·Status: COMPLETED
-
Build a Decision Aid Tool to Help Emergency Intensive Care Specialists in the Context of Hypoxic Ischemic Encephalopathy
NCT05114070 ·Status: COMPLETED
-
Dose Optimization of Caffeine for HIE
NCT06448780 ·Status: RECRUITING ·Phase: PHASE1
-
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
NCT05395195 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia
NCT00147030 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease
NCT02395783 ·Status: TERMINATED ·Phase: PHASE2/PHASE3